Exclusive Interview : Mykolas Majauskas the Lithuanian rep of legalization

Publicité

Nouvelles Variétés Sweet Seeds

Today, Thursday, October 11, 2018, the Seimas, the Lithuanian parliament has voted by a very large majority, the legalization of medicinal products containing Cannabis for medical use. Focus and exclusive interview with Le Cannabiste.

* * *

23621229 1949444378606270 1605504935762697520 n

#Lex

90 votes could be cast on 140 and 3 deputies abstained. It is now up to the President Dalia Grybauskaite to validate the law for enactment, but that should not pose any particular problem.

Nothing is planned to allow the use of flowers and Cannabis treatments will be reserved for serious and disabling diseases such as multiple sclerosis, cancer or autoimmune diseases.

 

41195641 2123387844545255 7515229320936161280 n

#1 year

This is the time it has taken since the initiative of Mykolas Majauskas of the Lithuanian Conservative Party TS-LKD to carry out its reform with the endorsement of the Minister of Health Aurelijus Verygu.

#Interview

-50 pourcent stormrock avec lecannabiste

Several gray areas surrounded this official announcement about Cannabis Médical in Lithuania. So we went directly to ask our questions to Mykolas Majauskas from the HUCD parti and of the EPP group, it is a political movement of the center right in Lithuania.

 

43381112 10204764582709805 4430128104328921088 n 1

LC: Hi Mykolas, where did you get the idea of ​​proposing the legalization of Medical Cannabis?  How long have you started fighting for this?

« It took 12 months for legislation to pass and now additional 6 months for all regulations to be put in place. Patients and their relatives were the main force behind the change. Their have share their personal experiences publicly that tilted public opinion in favour to legalise cannabis for medical treatment. »

 

27973753 1987434424807265 7350063900276502752 n

LC: Can the Cannabis flower be considered a medicine too?

« The legislation will not make the flower as a whole available in pharmacies. That was not the intention of our campaign nor could be considered as a realistic first step. However the new law opens up public discussion of what further changes are required to provide patients with the best possible treatment.

LC: Have you thought about the question of Cannabis’s personal cultivation in order to make her home medicine from flowers as oil or balms for the sick? 

First step is only introduction of medicine registered in EU, that contains cannabinoids. This will get foot in the door to explore the topic further in the near future. »

 

#2 numbers

-50 pourcent stormrock avec lecannabiste

Before leaving to return to our good old anxiolytics, antidepressants and other opiates massively consumed on the French soil, we quickly documented you on the Lithuanian context with 2 figures carefully selected for you :

32 Suicides per 100,000 inhabitants in 2014 is more than twice France, 6 times more than in Greece in the midst of the economic crisis.

18486239 1873534779530564 9121718105745365263 n

45,940 : this is the number of consultations for psychological disorders in Lithuania in 2016, a figure that has increased by more than 100% since 2014..

18423886 1871511303066245 298487320850066192 n

Let’s hope for Lithuania a happy legalization of medical marijuana, this is a country that we are going to follow with a magnifying glass in the coming months.

# freedom #newworld #medicalcannabis

Interview made on October the 12th of 2018

Commentaires, réactions: Le Cannabiste sur Facebook / Twitter

— Jean-pierre Ceccaldi pour The Blinc Group – Le Cannabiste 2018 Tous droits réservés –

-50 pourcent stormrock avec lecannabiste

 

A propos Jean-Pierre 1227 Articles
Fondateur et rédacteur du média Le Cannabiste. Je suis un journaliste autodidacte spécialisé dans le domaine du Cannabis. J'ai été choisi par un incubateur de Cannabusiness New Yorkais pour devenir leur consultant permanent en matière de Cannabis. Je publie de nombreux articles interviews et essais en langue Anglaise ainsi que pour la presse Française et l'industrie du Cannabis en général.